Literature DB >> 22085818

Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population.

Rok Seon Choung1, G Richard Locke, Cathy D Schleck, Alan R Zinsmeister, L Joseph Melton, Nicholas J Talley.   

Abstract

OBJECTIVES: In patients with diabetes mellitus (DM) and upper gastrointestinal symptoms, a diagnosis of diabetic gastroparesis is often considered, but population-based data on the epidemiology of diabetic gastroparesis are lacking. We aimed to estimate the frequency of and risk factors for gastroparesis among community subjects with DM.
METHODS: In this population-based, historical cohort study, the medical records linkage system of the Rochester Epidemiology Project was used to identify 227 Olmsted County, MN residents with type 1 DM in 1995, a random sample of 360 residents with type 2 DM, and an age- and sex-stratified random sample of 639 nondiabetic residents. Using defined diagnostic criteria, we estimated the subsequent risk of developing gastroparesis in each group through 2006. The risk in DM, compared with frequency-matched community controls, was assessed by Cox proportional hazards modeling.
RESULTS: The cumulative proportions developing gastroparesis over a 10-year time period were 5.2% in type 1 DM, 1.0% in type 2 DM, and 0.2% in controls. The age- and gender-adjusted hazard ratios (HRs) for gastroparesis (relative to controls) was 33 (95% confidence interval (CI): 4.0, 274) in type 1 DM and 7.5 (95% CI: 0.8, 68) in type 2 DM. The risk of gastroparesis in type 1 DM was significantly greater than in type 2 DM (HR: 4.4 (1.1, 17)). Heartburn (HR: 6.6 (1.7, 25)) at baseline was associated with diabetic gastroparesis in type 1 DM.
CONCLUSIONS: Gastroparesis is relatively uncommon in patients with DM, although an increased risk for gastroparesis was observed in type 1 DM.

Entities:  

Mesh:

Year:  2011        PMID: 22085818      PMCID: PMC3280088          DOI: 10.1038/ajg.2011.310

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  35 in total

1.  Gastrointestinal tract symptoms among persons with diabetes mellitus in the community.

Authors:  D Maleki; G R Locke; M Camilleri; A R Zinsmeister; B P Yawn; C Leibson; L J Melton
Journal:  Arch Intern Med       Date:  2000-10-09

Review 2.  Gastroparesis: clinical update.

Authors:  Moo-In Park; Michael Camilleri
Journal:  Am J Gastroenterol       Date:  2006-05       Impact factor: 10.864

Review 3.  Treatment of gastroparesis: a multidisciplinary clinical review.

Authors:  T L Abell; R K Bernstein; T Cutts; G Farrugia; J Forster; W L Hasler; R W McCallum; K W Olden; H P Parkman; C R Parrish; P J Pasricha; C M Prather; E E Soffer; R Twillman; A I Vinik
Journal:  Neurogastroenterol Motil       Date:  2006-04       Impact factor: 3.598

4.  Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults.

Authors:  P Bytzer; N J Talley; M Leemon; L J Young; M P Jones; M Horowitz
Journal:  Arch Intern Med       Date:  2001-09-10

5.  Predictors of delayed gastric emptying in diabetes.

Authors:  K L Jones; A Russo; J E Stevens; J M Wishart; M K Berry; M Horowitz
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

6.  GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications.

Authors:  Peter Bytzer; Nicholas J Talley; Johann Hammer; Lisa J Young; Michael P Jones; Michael Horowitz
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

Review 7.  Diabetes mellitus and gastric emptying: questions and issues in clinical practice.

Authors:  Melvin Samsom; Adil Bharucha; John E Gerich; Kathrin Herrmann; Jörg Limmer; Rainer Linke; David Maggs; Jörg Schirra; Adrian Vella; Hans-Jürgen Wörle; Burkhard Göke
Journal:  Diabetes Metab Res Rev       Date:  2009-09       Impact factor: 4.876

8.  An advanced approach for the assessment of gastric motor function in long-term type 1 diabetes mellitus with and without autonomic neuropathy.

Authors:  Matthias Meier; Rainer Linke; Klaus Tatsch; Eberhard Standl; Oliver Schnell
Journal:  Clin Auton Res       Date:  2002-06       Impact factor: 4.435

9.  Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up.

Authors:  Carolyn Quan; Nicholas J Talley; Michael P Jones; Judith Spies; Michael Horowitz
Journal:  Am J Gastroenterol       Date:  2008-08       Impact factor: 10.864

10.  The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006.

Authors:  Hye-Kyung Jung; Rok Seon Choung; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; Lawrence A Szarka; Brian Mullan; Nicholas J Talley
Journal:  Gastroenterology       Date:  2008-12-24       Impact factor: 22.682

View more
  63 in total

1.  Vitamin C Improves Gastroparesis in Diabetic Rats: Effects on Gastric Contractile Responses and Oxidative Stress.

Authors:  Luisa Mota Da Silva; Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva; Daniele Maria-Ferreira; Olair Carlos Beltrame; José Eduardo da Silva-Santos; Maria Fernanda de Paula Werner
Journal:  Dig Dis Sci       Date:  2017-06-21       Impact factor: 3.199

Review 2.  Epidemiology and natural history of gastroparesis.

Authors:  Adil E Bharucha
Journal:  Gastroenterol Clin North Am       Date:  2014-12-18       Impact factor: 3.806

3.  Botulinum Toxin A Improves Symptoms of Gastroparesis.

Authors:  Zachary Wilmer Reichenbach; Steven Stanek; Shyam Patel; Sara Jane Ward; Zubair Malik; Henry P Parkman; Ron Schey
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

4.  Suffering in Silence: Is Gastroparesis Underdiagnosed?

Authors:  Dennis J Baumgardner
Journal:  J Patient Cent Res Rev       Date:  2019-04-29

5.  How I Do It: Per-Oral Pyloromyotomy (POP).

Authors:  Matthew T Allemang; Andrew T Strong; Ivy N Haskins; John Rodriguez; Jeffrey L Ponsky; Matthew Kroh
Journal:  J Gastrointest Surg       Date:  2017-07-27       Impact factor: 3.452

Review 6.  Botulinum Toxin as a Treatment for Refractory Gastroparesis: a Literature Review.

Authors:  Ashley Thomas; Bruno de Souza Ribeiro; Miguel Malespin; Silvio W de Melo
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 7.  Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.

Authors:  Nelson Valentin; Andres Acosta; Michael Camilleri
Journal:  Expert Opin Investig Drugs       Date:  2015-06       Impact factor: 6.206

Review 8.  Gastroparesis: a turning point in understanding and treatment.

Authors:  Madhusudan Grover; Gianrico Farrugia; Vincenzo Stanghellini
Journal:  Gut       Date:  2019-09-28       Impact factor: 23.059

9.  Diabetic Gastroparesis: A Review.

Authors:  Clipper F Young; Marianne Moussa; Jay H Shubrook
Journal:  Diabetes Spectr       Date:  2020-08

10.  Gastrointestinal complications of diabetes mellitus.

Authors:  Babu Krishnan; Shithu Babu; Jessica Walker; Adrian B Walker; Joseph M Pappachan
Journal:  World J Diabetes       Date:  2013-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.